Introduction: In the context of the continuous quest to improve the care of the neonates especially the critically ill premature, the extended role of pharmacists in the process of parenteral nutrition order writing and effective participation in decision-making especially in the neonatal population is increasingly important.
The overall impression is that the practice of pharmacist writing neonatal parenteral nutrition orders already exists, but still limited if compared with the practice pharmacist writing adult parenteral nutrition orders which is much more established in many countries.
There was no single clinical study evaluating this practice, as we were able to retrieve only two surveys, which make it difficult to evaluate the pharmacists' role in this area.
Nevertheless, despite the wide variation in literature types, characteristics and quality, there are consistent patterns across all the reviewed literature that competencies of the pharmacist in this field are well represented, which make it very important to carry out good quality clinical studies in this field.
Finally, we are currently conducting a prospective clinical study to evaluate the impact of clinical pharmacist as a neonatal PN prescriber, this impact will be judged through the study outcomes as reducing the metabolic and electrolytes complications and increasing the mean daily weight gain during PN therapy and reducing the average number of days of PN till enteral feeding is achieved.
Introduction
Neonates are the most patients population that benefits from parenteral nutrition therapy, as most of the prematures and very low birth weight infants <1500 g will need immediate after birth nutrition support therapy through parenteral access due to their inability to tolerate/contraindicated enteral or oral feeding. As such, parenteral nutrition (PN) is an essential component of care for those infants. There is good evidence that some preterm infants may fail to grow adequately (Ehrenkranz et al., 1999; Wood et al., 2003) . Poor growth can be associated with poor neurodevelopmental outcomes in extremely preterm infants, with a lower weight at discharge associated with an increased risk of neurodevelopmental impairment (Ehrenkranz et al., 2006) . One reason for this poor growth may be that these infants receive inadequate nutrition in the first weeks of life.
Recommendations for the optimal nutrient intake of preterm infants exist (Agostoni et al., 2010) , however, there is evidence that these targets are not achieved (Embleton et al., 2001; Grover et al., 2008; Martin et al., 2009) . Achieving recommended nutrient intakes in these infants is a major challenge, and feeding practices can be variable. This was demonstrated by Cooke et al. (2004) who showed that units offering the same level of care had significant variations in postnatal growth. Another unique problem, frequently encountered with the neonatal parenteral nutrition ordering practice is the provision of low calories and failure to reach the minimum required calories needed for proper weight gain, and this problem is of great significance as the single most important goal for neonatal parenteral nutrition is to maximize weight gain and provide enough calories and protein to build new tissues. And to ensure the provision of the required calories and protein for those infants; the pharmacist input is of great significance as to calculate the daily provided calories and protein -from parenteral and enteral nutrition -for the infants and to modify the parenteral nutrition orders accordingly until reaching the goals.
Understanding the barriers to implementing a change in practice is key to the development of a successful intervention (Grol, 1997; Grol and Grimshaw, 2003) , and there is evidence that guidelines alone are often not enough to bring about or maintain a change in practice, and that more multifaceted implementation strategies are required (Grimshaw et al., 2004; Grol, 2001; Grol and Grimshaw, 2003; Mettes et al., 2010) .
Evidence demonstrates that physicians have minimal training and experience in this area of nutrition support (Gales and Riley, 1994) , and consequently this has led to the development of multidisciplinary nutrition support teams in many health care facilities (Naylor et al., 2004) . According to a position paper by the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPHGAN) Committee on Nutrition, current education of pediatricians in clinical nutrition is insufficient to ensure appropriate assessment of nutritional risk (Agostoni et al., 2005) .
Improvements can be made in the nutrition support process. The nutrition support pharmacist will be a key participant in the maintenance and improvement of the nutrition care process (Mirtallo, 2007) . In a recent article, reviewers proposed a paradigm shift of pharmacy nutrition support to move beyond PN and drug-nutrient interactions and become partners in the interdisciplinary approach to nutrition care plans and offer their assistance with the nutrition care plan's implementation and monitoring of its effectiveness (Mirtallo and Sacks, 2013) .
In the context of our continuous quest to improve the level of care to the neonates especially the critically ill prematures, the extended role of pharmacists in the process of parenteral nutrition order writing and effective participation in decision making especially in the neonatal population is increasingly important to better utilizing the pharmacists' vast pharmaceutical, pharmacological and clinical knowledge.
In this review we are mainly concentrating on the current areas of involvement for pharmacist in the neonatal parenteral nutrition practice. Also we aim at determining the impact of the pharmacist involvement in this practice on the patients' clinical outcomes and/or cost optimization of PN therapy. Throughout this review we will investigate if the pharmacist as a prescriber of neonatal PN orders had favorable impact on the patients' clinical status.
Materials and methods
An extensive literature review was conducted across various literature databases including, British Medical Journals (BMJ), Cochrane Library Database, EBSCO, Karger Journals, OVID SP, SAGE Journals, Science Direct, Scopus Database, Springer Link, Web Of Knowledge (ISI).
The search was conducted based on a diversity of key words related to the review topic, during the period from 1979 to 2013.
Keywords used for searching in various data sources: Neonate, Neonatal intensive care unit, premature, preterm, parenteral nutrition, total parenteral nutrition, pharmacy, clinical pharmacist, and pharmacist.
The articles were included in the final review only if they focused on and/or reported the pharmacists' involvement in parenteral nutrition practice other than the compounding of parenteral nutrition admixtures.
Then the results were reviewed to exclude the irrelevant articles, the articles were excluded from the final review if they were not reporting any involvement of the pharmacist in parenteral nutrition practice except only the compounding and preparation of parenteral nutrition admixtures.
Finally there were 19 articles matching the review topic. The selected articles were classified according to their type as: Commentary review (no. = 1), Descriptive review (no. = 4), Survey (no. = 6), Systematic review (no. = 1), Retrospective studies (no. = 2), Prospective study (no. = 3), Standards of practice (no. = 1), other (no. = 1).
Results
The key characteristics of the 19 literatures selected for inclusion in the final review out of 7127 searched published papers are outlined in Table 1 .
The search conducted over the previously mentioned databases yielded the following results: The included literatures cover a wide range of different pharmacists' involvement in neonatal parenteral nutrition practice, ranging from only compounding the PN admixtures through monitoring and participation in the decision-making process to the point of writing PN orders.
Worth mentioning that the definitions of pharmacist involvement in the PN therapy varies across the literature and in a number of cases, adequate descriptions of the involvement being studied were relatively limited, making comparisons more difficult.
Also it was noticed that there was a wide range of variation related to the quality of literature ranging from prospective studies all the way to just commentary article.
Finally few articles were discussing the pharmacist involvement in neonatal PN ordering process, while most of the articles were focusing on other outcomes and occasionally reporting the pharmacist involvement in PN practice, this finding make it much more difficult to extract these data related to the scope of our review.
Discussion
Based on the results of the literature search outlined in Table 1 , the focus of the literature was benefits of nutrition support team: (n = 2), variable levels of pharmacist involvement in PN, other than writing PN orders: (n = 9), benefits of pharmacist involvement in PN: (n = 5), pharmacist writing PN orders: (n = 6), and pharmacist writing neonatal PN orders: (n = 2).
From this stratification we noticed that only 2 articles (Ahmed et al., 2004; Mulholland, 2013) were focusing on pharmacist writing neonatal PN orders, and these articles were both surveys, which raise the need for more in-depth research to evaluate the benefits of pharmacist writing neonatal PN orders from the clinical point of view, also we need more clinical trials in this area.
Benefits of nutrition support team
This was discussed in two articles, the first confirm that the cost of PN will be reduced with the NST (Naylor et al., 2004) .
The second article confirms fewer metabolic abnormalities with the NST (Gales and Riley, 1994) .
Both articles were focusing on adult cases only.
Variable levels of pharmacist involvement in PN, other than writing PN orders
Most of the literature lies in this category as there are 9 articles focusing on different levels of pharmacist involvement in PN.
1. Nutrition care plan's implementation and monitoring (Mirtallo and Sacks, 2013) . 2. Nutrition consultations (MacLaren et al., 2006; Pedersen et al., 2011) . 3. Compounding of PN and are responsible for the logistical aspects and integrity of the PN product lines (Batani et al., 2007) . Respondents indicated that dietitians and pharmacists were heavily involved in the order-writing process, either as individuals or as members of a nutrition support service. The pharmacy was allowed to adjust certain electrolyte additives such as acetate or chloride in 62% of respondent's organizations. The oversight of the order-writing process was most often the responsibility of the pharmacy (71%).
(continued on next page) The main medicines being prescribed were Parenteral Nutrition (PN) (75%). Benefits of pharmacist prescribing: Improvement in safety was seen as a benefit of pharmacist prescribing, with potential reduction in communication errors (with the pharmacist making a change in medication or dosage, rather than asking a doctor to do it) and the ability to make timely correction of wrong prescriptions. Pharmacist knowledge of PN and pharmacokinetics were seen to be better utilized with the person advising now also taking the prescribing responsibility.
It was also felt that being a prescriber helped the pharmacist to integrate more into the multidisciplinary team. The unit-based pharmacist is responsible for initiation and daily management of PN along with the primary service physicians. The specialty practice pharmacist is responsible for oversight of the PN system throughout the entire health system.
(continued on next page) Focusing on the pharmacist consultation without clear mentioning on pharmacist writing PN.
Not clear the impact of pharmacist involvement. 2010 survey results: 52.4% of pharmacy programs provide nutrition consultation, and when provided, more than 99.3% have more than 80% of their consultations accepted by the prescriber.
2007 survey results: 48.4% of pharmacy programs provide nutrition consultation, and when provided, more than 98.4% have more than 80% of their consultations accepted by the prescriber.
2004 survey results: 51.1% of pharmacy programs provide nutrition consultation, and when provided, more than 91.6% have more than 80% of their consultations accepted by the prescriber.
2001 survey results: 46.7% of pharmacy programs provide nutrition consultation, and when provided, more than 76.9% have more than 80% of their consultations accepted by the prescriber.
19 Gales and Riley (1994) USA Prospective study 28 adult patients Adults Focusing only on adult cases. Focusing on the impact of nutrition support team (NST) without clear mentioning the impact of pharmacist in PN.
Patients followed by the NST were more likely to receive adequate nutrition and experience fewer metabolic abnormalities than when TPN therapy was guided solely by a physician.
Evidence demonstrates that physicians have minimal training and experience in this area of nutrition support. PN: parenteral nutrition; ICU's: intensive care units; TPN: total parenteral nutrition; NST: nutrition support team; NICU: neonatal intensive care unit; ASPEN: American society of parenteral and enteral nutrition; EN: enteral nutrition; NS: nutrition support; ASHP: American society of health system pharmacists. 4. Confirming or modifying the daily amounts of calories provided (Yang et al., 2013) . 5. Adjusting electrolytes additives in PN (Seres et al., 2006) . 6. The oversight of the order-writing process (Seres et al., 2006) . 7. Monitoring neonatal PN (Dice et al., 1981; Mutchie et al., 1979) . 8. Attend NST rounds (Strausburg, 1995) . 9. Assist NST members and others in designing patient specific NS regimens (Strausburg, 1995) .
These diverse activities carried out by pharmacists in the PN practice, if combined, will definitely enable the pharmacist of writing PN orders; either for adults or neonates.
Benefits of pharmacist involvement in PN
There were 5 articles focusing on the benefits of the pharmacist involvement in PN which are:
1. More appropriate parenteral nutrition therapy (McDermott et al., 1994) . 2. Earlier transitioning from parenteral to enteral nutrition (McDermott et al., 1994) . 3. Recognition of staff pharmacists as resources by the physicians (McDermott et al., 1994) . 4. Increased job satisfaction for pharmacists (McDermott et al., 1994) . 5. Reduce the pharmacy's costs and patient charges for TPN (Dice et al., 1981; Mutchie et al., 1979 ). 6. Improved the patients' clinical responses to TPN (Mutchie et al., 1979) . 7. Reduction in communication errors (Mulholland, 2013) . 8. More integration into the multidisciplinary team (Mulholland, 2013 ). 9. Fewer clarifications are required (Boullata et al., 2013) . 10. Less medications errors (Boullata et al., 2013) . 11. Greater mean daily weight gain for neonates (Dice et al., 1981) . 12. Greater amount of nutrients to be provided to neonates (Dice et al., 1981) .
Pharmacist writing PN orders
There were 6 articles focusing on the pharmacist writing PN orders but in all of them the patients were of mixed population and/or it was difficult to extract the data for neonates.
1. In the web based survey by Seres et al. (2006) , pharmacists were heavily involved in PN writing process (Seres et al., 2006) . 2. In the review by Greenlaw (1979) , the pharmacist is responsible solely of writing PN orders (Greenlaw, 1979) . 3. This is from the ASPEN standards of practice for nutrition support pharmacists stating that nutrition support pharmacist may write orders for feeding formulations (Rollins et al., 2008) . 4. In the survey by Boullata et al. (2013) , 28.3% of respondents reported that a pharmacist was prescribing PN (Boullata et al., 2013) .
5.
In the clinical observation review by Mirtallo et al. (2009) , the unit-based pharmacist was responsible for initiation of PN (Mirtallo et al., 2009 ). 6. In the descriptive review by Faber (1991) , six pharmacists completed the training program and were allowed to write PN orders and conduct PN rounds (Faber, 1991) .
We noticed that all the 6 articles were either reviews or surveys or poster presentation, and no single clinical trial was available to judge the practice of pharmacist writing PN orders; which again raise the need for good quality clinical research on this area.
Pharmacist writing neonatal PN orders
Finally we reach to the articles covering the exact scope of this literature review, and there were only 2 surveys in this group.
1. In the first survey by Mansoor et al., 2004 , only three of the surveyed neonatal units reported that the person responsible for ordering PN was a pharmacist (Ahmed et al., 2004) . 2. In the second survey by Mulholland (2013) , he reported that the main medications being prescribed by the respondent pharmacists (n = 45), were parenteral nutrition (75%) (Mulholland, 2013) .
But the limitations for both articles are the lack of objectivity and small size of the surveys.
Worth mentioning that in the study by Batani et al. (2007) , which was carried out at USM, Malaysia (Batani et al., 2007) , the rate of electrolyte and metabolic complications was 56.5% which is higher compared with that in developed countries, also in this study the pharmacist role was only compounding of the PN admixtures (Batani et al., 2007) .
While in the study of Gales and Riley (1994) , they demonstrated that adding a pharmacist to the nutrition support team with direct interventions in the nutritional care plan, will reduce the metabolic and electrolyte complications associated with parenteral nutrition therapy (Gales and Riley, 1994) .
This could make us assume that in the study of Batani et al. (2007) . If the pharmacists had better role in the PN process this could have reduced the metabolic and electrolyte complications encountered.
Conclusion
Overall, the review presents the up-to-date status of the most recent analysis being undertaken on the topic of pharmacist involvement in the parenteral nutrition order writing practices and more specific in the neonatal population over the period from 1979 to 2013.
It is very difficult to assess the usefulness of the practice of pharmacist writing neonatal parenteral nutrition orders in the view of lack of good quality clinical trials evaluating this practice in the real life, there was no single clinical study evaluating this practice, as we were able to retrieve only two surveys.
Nevertheless, despite the wide variation in literature types, characteristics and quality, there are consistent patterns across all the reviewed literature that competencies of the pharmacist in this field are well represented, which make it very important to carry out good quality clinical studies to assess the clinical benefits of the pharmacist involvement in writing neonatal parenteral nutrition orders.
Finally, based on all these findings, we are currently conducting a prospective clinical study with historical cohort control -at Prince Salman Northwestern Armed Forces Hospital, Tabuk -to evaluate the impact of clinical pharmacist as a neonatal PN prescriber, this impact will be judged through the study outcomes as reducing the metabolic and electrolytes complications and increasing the mean daily weight gain during PN therapy and reducing the average number of days of PN till enteral feeding is achieved.
